NCT04532567

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of GLPG1205 for 14 Days in Healthy Japanese and Caucasian Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Galapagos NV · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this research study is to assess the safety and tolerability of GLPG1205 in single and multiple oral doses in healthy male Caucasian and Japanese subjects. This study will also assess the pharmacokinetics (PK) across different doses of GLPG1205. PK will look at how the study drug is absorbed, broken down, and eliminated by your body.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	GLPG1205	GLPG1205 film-coated tablets
DRUG	Placebo	placebo film-coated tablets

Timeline

• Start date: 2020-08-18
• Primary completion: 2020-12-10
• Completion: 2020-12-10
• First posted: 2020-08-31
• Last updated: 2020-12-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study